Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Eff of Axicabtagene Ciloleucel vs SoC Thrpy in Sbjcts w/ Relapse/Refrac Diffuse Large B Cell Lymphom

Protocol: OSU-17326

Full Title

A Phase III, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel versus Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)

Lymphoma Non-Hodgkin’s Lymphoma (B- & T-Cell)